A preparation method of high-purity tegretol crystal form ii
By using acetone and toluene as solvents and combining primary and secondary purification methods, the problems of low purity and high cost of industrial production of ticagrelor have been solved, and high-purity ticagrelor has been prepared, which is suitable for industrial production of various dosage forms.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- JIANGSU PURUN BIO-MEDICAL CO LTD
- Filing Date
- 2023-11-14
- Publication Date
- 2026-07-24
AI Technical Summary
In the existing technology, ticagrelor has low purity, high solvent toxicity, uneven crystal particles, high industrial production cost, and poor crystal stability, making it difficult to meet the needs of various dosage forms.
Using acetone and toluene as solvents, solvent residue and purity were controlled through primary and secondary purification methods. The ratio of acetone to toluene was 1:9.0–11.0 and 1:0.5–1.5:9–11, and the temperature and time were controlled to achieve the preparation of high-purity ticagrelor.
It increases the purity of ticagrelor to 99.90%, reduces production costs, has high solvent safety, is easy to recycle and reuse, has stable crystal form, and is suitable for industrial production.
Smart Images

Figure CN117510508B_ABST